GlassScriptPhysician profile
Mohammad S Hussain
NPI 1710051537
$15,084.06
in general payments reported to CMS, 2019-2025
68 companies · $3,017 in 2025
The $3,017 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,413 · 2020: $1,683 · 2021: $2,133 · 2022: $2,022 · 2023: $2,361 · 2024: $2,455 · 2025: $3,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,826 · Education: $7.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,825.76 |
| Education | $7.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,966.69 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,687.50 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $808.79 | 2019-2025 | Xifaxan, Trulance |
| Horizon Therapeutics Plc | $784.25 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $752.29 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $584.38 | 2021-2025 | |
| Lilly USA, LLC | $575.62 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $524.29 | 2019-2025 | Jardiance |
| Incyte Corporation | $465.98 | 2019-2022 | |
| Mylan Specialty L.P. | $348.61 | 2019-2024 | Yupelri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $348.08 | 2022-2025 | Caplyta |
| Pfizer INC. | $334.41 | 2020-2025 | |
| Sunovion Pharmaceuticals INC. | $316.53 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $300.65 | 2024-2025 | Fanapt, Hetlioz |
| Amgen INC. | $281.61 | 2019-2025 | Repatha, Otezla, Otezla |
Show all 68 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $278.79 | 2019-2025 | Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $267.22 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $244.69 | 2019-2025 | |
| Novo Nordisk INC | $240.48 | 2019-2025 | Ozempic, Rybelsus |
| Amarin Pharma, INC. | $234.73 | 2019-2021 | |
| Exact Sciences Corporation | $230.67 | 2023-2025 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $204.78 | 2019-2024 | Eliquis |
| Dexcom, INC. | $192.18 | 2022-2025 | Dexcom G6 Transmitter |
| Axsome Therapeutics, INC. | $184.54 | 2022-2025 | Symbravo, Auvelity |
| Ceribell, INC. | $171.36 | 2025 | Pocket Eeg Device |
| Allergan, INC. | $168.20 | 2019-2020 | |
| Lundbeck LLC | $161.32 | 2023-2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $156.15 | 2023-2024 | Rexulti |
| Penumbra, INC. | $146.40 | 2025 | Indigo System |
| Merck Sharp & Dohme LLC | $144.46 | 2019-2025 | Verquvo, Gardasil 9, Capvaxive |
| Ani Pharmaceuticals, INC. | $141.28 | 2025 | Purified Cortrophin Gel |
| Ardelyx, INC. | $137.57 | 2023-2025 | Ibsrela |
| Viatris Specialty LLC | $130.70 | 2025 | Yupelri |
| Alkermes, INC. | $125.67 | 2022-2025 | Aristada, Lybalvi |
| Sumitomo Pharma America, INC. | $111.39 | 2023-2024 | Gemtesa |
| Abbott Laboratories | $109.35 | 2019-2024 | Freestyle Libre 3 |
| Idorsia Pharmaceuticals US INC | $108.57 | 2022-2023 | Quviviq |
| Biohaven Pharmaceuticals, INC. | $91.13 | 2021 | |
| Corium, LLC | $86.20 | 2023 | Adlarity |
| Eisai INC. | $73.54 | 2021 | |
| Endo Pharmaceuticals INC. | $67.22 | 2021 | |
| Boston Scientific Corporation | $64.05 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $59.51 | 2022 | |
| Scpharmaceuticals INC. | $55.26 | 2025 | |
| Xeris Pharmaceuticals, INC. | $39.49 | 2025 | Gvoke Hypopen |
| Philips North America LLC | $36.61 | 2020 | |
| Astellas Pharma US INC | $36.09 | 2020-2022 | |
| Shield Therapeutics INC | $36.00 | 2022-2023 | Accrufer |
| Evoke Pharma, INC. | $34.67 | 2021-2022 | |
| Linus Health, INC. | $32.58 | 2023 | |
| Phathom Pharmaceuticals, INC. | $32.19 | 2024 | Voquezna |
| Kowa Pharmaceuticals America, INC. | $31.29 | 2021-2025 | Zoryve |
| Hikma Pharmaceuticals USA | $30.73 | 2022 | |
| Aimmune Therapeutics, INC. | $26.00 | 2024 | |
| Forte Bio-Pharma LLC | $25.09 | 2021 | |
| Renalytix Ai, INC. | $24.12 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Cumberland Pharmaceuticals, INC. | $23.50 | 2024 | Kristalose |
| Rgh Enterprises LLC | $23.41 | 2025 | |
| Sk Life Science, INC. | $23.21 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $23.11 | 2021 | |
| Daiichi Sankyo INC. | $21.85 | 2021 | |
| Neurocrine Biosciences, INC. | $21.75 | 2022 | |
| Corcept Therapeutics | $17.63 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $17.47 | 2021 | |
| Cmp Pharma, INC. | $17.27 | 2021 | |
| Melinta Therapeutics, LLC | $16.36 | 2019 | |
| Medicure Pharma INC. | $13.34 | 2025 | Zypitamag |
| Intra-Sana Laboratories | $13.21 | 2024 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Hussain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.